evidence table
Black Seed Cholesterol Randomized Trial Evidence Table
Structured evidence table for Black Seed Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Black Seed Cholesterol Randomized Trial | Quality assessment, including risk of bias, was performed using the Jadad checklist. | 1 | Dashti S (2026) | Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. |
| Black Seed Cholesterol Randomized Trial | BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age and one of the important causes of infertility due to a lack of ovulation. | 1 | Dashti S (2026) | Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. |
| Black Seed Cholesterol Randomized Trial | OBJECTIVE: Given the consideration of herbal medicines in the treatment of this condition, this systematic review was conducted to investigate the effect of herbal compounds on the treatment of PCOS. | 1 | Dashti S (2026) | Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. |
| Black Seed Cholesterol Randomized Trial | Additionally, the risk of disease development is significantly increased by comorbidities such as obesity, type 2 diabetes, and metabolic syndrome []. | 3 | Fic Weronika (2026) | Thymoquinone in Atherosclerosis: A Multi-Target Nutraceutical Modulating Inflammation, Oxidative Stress, and Lipid Metabolism |
| Black Seed Cholesterol Randomized Trial | Excessive enlargement of the necrotic core relative to the thickness of the fibrous cap increases the risk of plaque rupture and thrombus formation []. | 3 | Fic Weronika (2026) | Thymoquinone in Atherosclerosis: A Multi-Target Nutraceutical Modulating Inflammation, Oxidative Stress, and Lipid Metabolism |
| Black Seed Cholesterol Randomized Trial | This study was conducted as a narrative review, the aim of which was to critically analyze the available scientific evidence regarding the role of TQ in modulating processes associated with atherosclerosis development, with a particular focus on inflammation, oxidative stress, and lipid metabolism disorders. | 3 | Fic Weronika (2026) | Thymoquinone in Atherosclerosis: A Multi-Target Nutraceutical Modulating Inflammation, Oxidative Stress, and Lipid Metabolism |
| Black Seed Cholesterol Randomized Trial | 1 2 3 2 3 4 5 5 6 2 In recent years, a significant increase in the prevalence of chronic cardiovascular diseases (CVD) has been reported in both developed and developing countries. | 3 | Fic Weronika (2026) | Thymoquinone in Atherosclerosis: A Multi-Target Nutraceutical Modulating Inflammation, Oxidative Stress, and Lipid Metabolism |
Source documents